Trial intelligence / Profile preview

TS-1 vs TS-1+PSK in Stage II/IIIA Gastric Cancer

NCT00216034Phase 3Completed

Sponsor
Hokuriku-Kinki Immunochemotherapy Study Group
Start
Mar 2005
Primary completion
Feb 2016
Modality
Recombinant Proteins and Enzymes, Microbiome-Derived Products
Countries
1
01

Overview

A Phase 3 trial of polysaccharide k in gastric cancer (GC), sponsored by Hokuriku-Kinki Immunochemotherapy Study Group. Started Mar 2005; status: completed.

02

Drugs

polysaccharide k
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00216034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00216034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call